MedPath

江苏朗欧药业有限公司

Ownership
-
Established
2013-06-21
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

130

NMPA:130

Drug Approvals

Clonazepam Injection

Product Name
氯硝西泮注射液
Approval Number
国药准字H10900003
Approval Date
Nov 9, 2020
NMPA

Allitride Injection

Product Name
大蒜素注射液
Approval Number
国药准字H20055246
Approval Date
Oct 10, 2020
NMPA

Adenosine Disodium Triphosphate Injection

Product Name
三磷酸腺苷二钠注射液
Approval Number
国药准字H32024746
Approval Date
Oct 10, 2020
NMPA

Etamsylate Injection

Product Name
酚磺乙胺注射液
Approval Number
国药准字H32022157
Approval Date
Oct 10, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H32022150
Approval Date
Oct 10, 2020
NMPA

Granisetron Hydrochloride Injection

Product Name
盐酸格拉司琼注射液
Approval Number
国药准字H20054296
Approval Date
Oct 10, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H32022149
Approval Date
Oct 10, 2020
NMPA

Lidocaine Carbonate Injection

Product Name
碳酸利多卡因注射液
Approval Number
国药准字H20055377
Approval Date
Oct 10, 2020
NMPA

Etamsylate Injection

Product Name
酚磺乙胺注射液
Approval Number
国药准字H32022156
Approval Date
Oct 10, 2020
NMPA

Chlorprothixene Hydrochloride Injection

Product Name
盐酸氯普噻吨注射液
Approval Number
国药准字H32022137
Approval Date
Oct 10, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.